GLP-1 drugs have been marketed for nearly 20 years to treat diabetes, and their use in obesity is fueling a new market thats expected to hit $100 billion in 2030
If the benefit is feeling bronzed, the market is saturated in beautiful, non-harmful, low-tox self-tanner which has little to NO risks
The pain was persistent, and I often felt stiffness and discomfort that would last for days
Similarly 2024 guidelines published by ESC for atrial fibrillation management do not mention GLP-1 RAs as part of management [51]
A peptide is simply a short chain of amino acids, the building blocks of proteins
The Trump GLP-1 drug price deal, often referred to as TrumpRx, is a policy initiative designed to establish direct-purchase pricing tiers and negotiated options that lower patient out-of-pocket costs for select anti-obesity medications